Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 15, 2022

View Archived Issues

MKX regulates periodontal ligament homeostasis

HMB-001 bispecific antibody shows promise for treating Glanzmann thrombasthenia

University of Newcastle upon Tyne describes compounds for preventing DNA damage

Ubix Therapeutics presents PROTAC androgen receptor degraders

Dual PI3K-delta/PI3K-gamma inhibitors identified at National Institute of Pharmaceutical R&D Co.

New complement C1s subcomponent inhibitors discovered at Annexon

Mutant SLC6A8 correctors patented by Jnana Therapeutics

Cofilin siRNA, a promising therapy for treatment of hemorrhagic stroke

PSD3 downregulation as new therapeutic strategy against FLD

SETD2 loss promotes tumor metastasis in ccRCC

Studies at CROI show interferons' complex effects, therapeutic potential

Adcentrx and AvantGen partner to discover antibodies for ADC candidates

Therapeutics Solutions reports preclinical data on CampbellCell stem cell therapy for schizophrenia

Novel curcumin derivative, C-0818, inhibits proliferation and induces apoptosis in HCC cells

VDAC1 overexpression tied to ulcerative colitis

Tumor-associated HEVs predict response in melanoma patients receiving anti-PD-1/CTLA-4 combination

Genomic pan-cancer cohort including 25,000 patients identifies organ-specific metastatic patterns

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...